相关实验视频

Updated: Jun 29, 2025

Examining the Role of Nasopharyngeal-associated Lymphoreticular Tissue NALT in Mouse Responses to Vaccines

Examining the Role of Nasopharyngeal-associated Lymphoreticular Tissue NALT in Mouse Responses to Vaccines

Published on: August 1, 2012

lncRNA,血管认知障碍和免疫策略之间的潜在交叉点:洞察力和未来方向

Yishu Fan^1,2, Bo Xiao^1,2, Mengqi Zhang^1,2

¹Department of Neurology, Xiangya Hospital, Central South University, Changsha 410008, China.

|March 28, 2024

概括

长非编码RNAs (lncRNAs) 是血管认知障碍 (VCI) 的关键. 研究表明,lncRNA配置文件可以指导用于预防和治疗VCI的疫苗开发.

科学领域:

神经科学是一个神经科学.
基因组学就是基因组学.
免疫学免疫学免疫学

背景情况:

血管认知障碍 (VCI) 由于其复杂性而带来诊断挑战.
下一代测序 (NGS) 揭示了长非编码RNAs (lncRNAs) 在VCI的分子病理学中的作用.
神经炎症是VCI的一个关键因素,与脑血管问题有关.

研究的目的:

审查在VCI中的lncRNAs的功能.
探索 lncRNA 导向疫苗对 VCI 的潜力.
要突出 lncRNAs,VCI 和免疫学的交叉点.

主要方法:

综合文献综述,重点关注NGS数据和VCI中的lncRNA功能.
在VCI中分析免疫系统的作用和神经炎症过程.
探索 lncRNA 在免疫路径中的调节作用.

主要成果:

NGS技术提供了对lncRNAs在VCI中的参与的深入洞察.
lncRNAs参与调节与VCI相关的免疫反应.
根据 lncRNA 档案的信息,疫苗策略提供了一个新的治疗途径.

结论:

lncRNAs在VCI病原和免疫调节中至关重要.
基于lncRNA特征的向疫苗可以彻底改变VCI管理.
需要进一步的跨学科研究来验证这些发现.

关键词:

免疫学免疫学免疫学长非编码RNA (lncRNA) 是一种长非编码RNA.下一代测序 (NGS) 是指下一代的测序.疫苗疫苗疫苗疫苗血管性认知障碍 (VCI) 是一种

更多相关视频

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis

Published on: November 22, 2024

相关概念视频

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...